RAMM Pharma Income Statement

Financials in millions CAD. Fiscal year is November - October.

Millions CAD. Fiscal year is Nov - Oct.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Revenue	3.36	4.34	5.07	3.9	4.12
Revenue Growth (YoY)	-22.60%	-14.28%	29.97%	-5.31%	-24.40%
Cost of Revenue	2.51	2.57	4.64	3.41	4.15
Gross Profit	0.85	1.78	0.42	0.48	-0.04
Selling, General & Admin	5.3	8.42	7.36	8.42	6.6
Other Operating Expenses	0.08	0.12	0.15	-	-
Operating Expenses	5.38	10.72	7.51	8.42	6.6
Operating Income	-4.53	-8.94	-7.09	-7.94	-6.64
Interest Expense	-0.24	-0.04	-0.05	-0.01	-0.01
Interest & Investment Income	0.01	0.03	0.2	0.16	0.37
Earnings From Equity Investments	-	-	-	-	-0.71
Currency Exchange Gain (Loss)	-0.07	-0	-0.04	0.08	-0.3
Other Non Operating Income (Expenses)	-0.05	0.02	0.35	0.17	0.03
EBT Excluding Unusual Items	-4.89	-8.93	-6.64	-7.54	-7.26
Impairment of Goodwill	-	-	-	-12.93	-
Gain (Loss) on Sale of Investments	-	-	-	-0.23	0.27
Gain (Loss) on Sale of Assets	0.77	-	-	-	-
Asset Writedown	-4.77	-7.56	-1.07	-0.25	-
Other Unusual Items	-	-	-	-	-0.11
Pretax Income	-8.89	-16.49	-7.71	-20.95	-7.1
Income Tax Expense	0.02	0.01	0.01	0.01	0.01
Net Income	-8.91	-16.5	-7.72	-20.96	-7.11
Net Income to Common	-8.91	-16.5	-7.72	-20.96	-7.11
Shares Outstanding (Basic)	119	119	121	123	108
Shares Outstanding (Diluted)	119	119	121	123	108
Shares Change (YoY)	-	-1.36%	-1.42%	13.20%	7.85%
EPS (Basic)	-0.07	-0.14	-0.06	-0.17	-0.07
EPS (Diluted)	-0.07	-0.14	-0.06	-0.17	-0.07
Free Cash Flow	-1.06	-4.05	-4.4	-6.08	-4.26
Free Cash Flow Per Share	-0.01	-0.03	-0.04	-0.05	-0.04
Gross Margin	25.25%	40.92%	8.34%	12.43%	-0.91%
Operating Margin	-134.83%	-205.86%	-139.90%	-203.64%	-161.37%
Profit Margin	-265.13%	-380.06%	-152.43%	-537.79%	-172.66%
Free Cash Flow Margin	-31.54%	-93.17%	-86.87%	-156.02%	-103.52%
EBITDA	-3.93	-7.97	-6.03	-7	-6.01
EBITDA Margin	-116.92%	-183.49%	-119.00%	-179.69%	-145.94%
D&A For EBITDA	0.6	0.97	1.06	0.93	0.63
EBIT	-4.53	-8.94	-7.09	-7.94	-6.64
EBIT Margin	-134.83%	-205.86%	-139.90%	-203.64%	-161.37%
Advertising Expenses	0.02	0.06	0.2	0.42	0.09

Source: S&P Global Market Intelligence. Standard template. Financial Sources.